Specific Signaling Pathways Triggered by IL-2 in Human Vγ9Vδ2 T Cells: An Amalgamation of NK and αβ T Cell Signaling

Journal of Immunology

Volumn 171, Issue 10, 2003, Pages 5225-5232

  Lafont, Virginie ^a   Loisel, Séverine ^a   Liautard, Janny ^a   Dudal, Sherri ^a   Sablé Teychené, Magali ^a   Liautard, Jean Pierre ^a   Favero, Jean ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALPHA BETA T LYMPHOCYTE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFECTION; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; VGAMMA9VDELTA2 T LYMPHOCYTE;

EID: 0242663870     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.10.5225     Document Type: Article

References (70)

1. Kabelitz, D., D. Wesch, and T. Hinz. 1999. γδ T cells, their T cell receptor usage and role in human diseases. Springer Semin. Immunopathol. 21:55.
2. Battistini, L., G. Borsellino, G. Sawicki, F. Poccia, M. Salvetti, G. Ristori, and C. F. Brosnan. 1997. Phenotypic and cytokine analysis of human peripheral blood γδ T cells expressing NK cell receptors. J. Immunol. 159:3723.
3. De Libero, G. 1999. Control of γδ T cells by NK receptors. Microbes Infect. 1:263.
4. Kabelitz, D., A. Glatzel, and D. Wesch. 2000. Antigen recognition by human γδ T lymphocytes. Int. Arch. Allergy Immunol. 122:1.
5. Constant, P., F. Davodeau, M. A. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, and J. J. Fournie. 1994. Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 264:267.
6. Tanaka, Y., S. Sano, E. Nieves, G. De Libero, D. Rosa, R. L. Modlin, M. B. Brenner, B. R. Bloom, and C. T. Morita. 1994. Nonpeptide ligands for human γδ T cells. Proc. Natl. Acad. Sci. USA 91:8175.
7. Ottones, F., J. Liautard, A. Gross, F. Rabenoelina, J. P. Liautard, and J. Favero. 2000. Activation of human Vγ9Vδ2 T cells by a Brucella suis non-peptidic fraction impairs bacterial intracellular multiplication in monocytic infected cells. Immunology 100:252.
8. Feurle, J., E. Espinosa, S. Eckstein, F. Pont, V. Kunzmann, J. J. Fournie, M. Herderich, and M. Wilhelm. 2002. Escherichia coli produces phosphoantigens activating human γδ T cells. J. Biol. Chem. 277:148.
9. Behr, C., R. Poupot, M. A. Peyrat, Y. Poquet, P. Constant, P. Dubois, M. Bonneville, and J. J. Fournie. 1996. Plasmodium falciparum stimuli for human γδ T cells are related to phosphorylated antigens of mycobacteria. Infect. Immun. 64:2892.
10. Tanaka, Y., C. T. Morita, E. Nieves, M. B. Brenner, and B. R. Bloom. 1995. Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 375:155.
11. Bukowski, J. F., C. T. Morita, Y. Tanaka, B. R. Bloom, M. B. Brenner, and H. Band. 1995. Vγ2Vδ2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 154:998.
12. Lafont, V., J. Liautard, A. Gross, J. P. Liautard, and J. Favero. 2000. Tumor necrosis factor-α production is differently regulated in γδ and αβ human T lymphocytes. J. Biol. Chem. 275:19282.
13. Garcia, V. E., P. A. Sieling, J. Gong, P. F. Barnes, K. Uyemura, Y. Tanaka, B. R. Bloom, C. T. Morita, and R. L. Modlin. 1997. Single-cell cytokine analysis of γδ T cell responses to nonpeptide mycobacterial antigens. J. Immunol. 159:1328.
14. Lang, F., M. A. Peyrat, P. Constant, F. Davodeau, J. David-Ameline, Y. Poquet, H. Vie, J. J. Fournie, and M. Bonneville. 1995. Early activation of human Vγ9Vδ2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J. Immunol. 154:5986.
15. Sicard, H., T. Al Saati, G. Delsol, and J. J. Fournie. 2001. Synthetic phosphoantigens enhance human Vγ9Vδ2 T lymphocytes killing of non-Hodgkin's B lymphoma. Mol. Med. 7:711.
16. Ottones, F., J. Dornand, A. Naroeni, J. P. Liautard, and J. Favero. 2000. Vγ9Vδ2 T cells impair intracellular multiplication of Brucella suis in autologous monocytes through soluble factor release and contact-dependent cytotoxic effect. J. Immunol. 165:7133.
17. Dieli, F., M. Troye-Blomberg, J. Ivanyi, J. J. Fournie, M. Bonneville, M. A. Peyrat, G. Sireci, and A. Salemo. 2000. Vγ9/Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur. J. Immunol. 30:1512.
18. Carena, I., A. Shamshiev, A. Donda, M. Colonna, and G. D. Libero, 1997. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-γ/δ stimulated by nonpeptidic ligands. J. Exp. Med. 186:1769.
19. Halary, F., M. A. Peyrat, E. Champagne, M. Lopez-Botet, A. Moretta, L. Moretta, H. Vie, J. J. Fournie, and M. Bonneville. 1997. Control of self-reactive cytotoxic T lymphocytes expressing γδ T cell receptors by natural killer inhibitory receptors. Eur. J. Immunol. 27:2812.
20. Poccia, F., B. Cipriani, S. Vendetti, V. Colizzi, Y. Poquet, L. Battistini, M. Lopez-Botet, J. J. Fournie, and M. L. Gougeon. 1997. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive Vγ9Vδ2 T lymphocytes. J. Immunol. 159:6009.
21. Lafont, V., J. Liautard, J. P. Liautard, and J. Favero. 2001. Production of TNF-α by human Vγ9Vδ2 T cells via engagement of FeγRIIIA, the low affinity type 3 receptor for the Fe portion of IgG, expressed upon TCR activation by nonpeptidic antigen. J. Immumol. 166:7190.
22. Das, H., V. Groh, C. Kuijl, M. Sugita, C. T. Morita, T. Spies, and J. F. Bukowski. 2001. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity. 15:83.
23. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727.
24. Groh, V., R. Rhinehart, H. Secrist, S. Bauer, K. H. Grabstein, and T. Spies. 1999. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 96:6879.
25. Tieng, V., C. Le Bouguenec, L. du Merle, P. Bertheau, P. Desreumaux, A. Janin, D. Charron, and A. Toubert. 2002. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class 1-related molecule MICA. Proc. Natl. Acad. Sci. USA 99:2977.
26. Groh, V., R. Rhinehart, J. Randolph-Habecker, M. S. Topp, S. R. Riddell, and T. Spies. 2001. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:255.
27. Ellery, J. M., and P. J. Nicholls. 2002. Alternate signalling pathways from the interleukin-2 receptor. Cytokine Growth Factor Rev. 13:27.
28. Nelson, B. H., and D. M. Willerford. 1998. Biology of the interleukin-2 receptor. Adv. Immunol. 70:1.
29. Theze, J., P. M. Alzari, and J. Bertoglio. 1996. Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol. Today 17:481.
30. Smith, K. A. 1992. Interleukin-2. Curr. Opin. Immunol. 4:271.
31. Baume, D. M., M. J. Robertson, H. Levine, T. J. Manley, P. W. Schow, and J. Ritz. 1992. Difrerential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur. J. Immunol. 22:1.
32. Bonnema, J. D., K. A. Rivlin, A. T. Ting, R. A. Schoon, R. T. Abrabam, and P. J. Leibson. 1994. Cytokine-enhanced NK cell-mediated cytotoxicity: positive modulatory effects of IL-2 and IL-12 on stimulus-dependent granule exocytosis. J. Immunol. 152:2098.
33. Frank, D. A., M. J. Robertson, A. Bonni, J. Ritz, and M. E. Greenberg. 1995. Interleukin 2 signaling involves the phosphorylation of Stat proteins. Proc. Natl. Acad. Sci. USA 92:7779.
34. Beadling, C., D. Guschin, B. A. Witthuhn, A. Ziemiecki, J. N. Ihle, I. M. Kerr, and D. A. Cantrell. 1994. Activation of JAK kinases and STAT proteins by Interleukin-2 and interferon α, but not the T cell antigen receptor, in human T lymphocytes. EMBO J. 13:5605.
35. Johnston, J. A., C. M. Bacon, D. S. Finbloom, R. C. Rees, D. Kaplan, K. Shibuya, J. R. Ortaldo, S. Gupta, Y. Q. Chen, J. D. Giri, et al. 1995. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl. Acad. Sci. USA 92:8705.
36. Wang, K. S., J. Ritz, and D. A. Frank. 1999. IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells. J. Immunol. 162:299.
37. Lin, J. X., and W. J. Leonard, 1997. Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev. 8:313.
38. Yu, T. K., E. G. Caudell, C. Smid, and E. A. Grimm. 2000. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway. J. Immunol. 164:6244.
39. Moire, N., C. F. Calvo, D. Metivier, J. Y. Perrot, C. Vaquero, M. Hatakeyama, and A. Senik. 1990. Role of interleukin 2 receptor β chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells. Eur. J. Immunol. 20:1981.
40. Borrego, F., M. J. Robertson, J. Ritz, J. Pena, and R. Solana. 1999. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor. Immunology 97:159.
41. Bacon, C. M., E. F. Petricoin, 3rd. J. R. Ortaldo, R. C. Rees, A. C. Larner, J. A. Johnston, and J. J. O'Shea. 1995. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Nalt. Acad. Sci. USA 92:7307.
42. Bacon, C. M., D. W. McVicar, J. R. Ortaldo, R. C. Rees, J. J. O'Shea, and J. A. Johnston. 1995. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J. Exp. Med. 181:399.
43. Hou, J., U. Schindler, W. J. Henzel, S. C. Wong, and S. L. McKnight. 1995. Identification and purification of human Stat proteins activated in response to Interleukin-2. Immunity 2:321.
44. Imada, K., and W. J. Leonard. 2000. The Jak-STAT pathway. Mol. Immunol. 37:1.
45. Leonard, W. J., and J. J. O'Shea. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16:293.
46. Beadling, C., J. Ng, J. W. Babbage, and D. A. Cantrell. 1996. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J. 15:1902.
47. Yu, C. R., H. A. Young, and J. R. Ortaldo. 1998. Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells. J. Leukocyte Biol. 64:245.
48. Nielsen, M., A. Svejgaard, S. Skov, and N. Odum. 1994. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur. J. Immunol. 24:3082.
49. Ahmed, N. N., H. L. Grimes, A. Bellacosa, T. O. Chan, and P. N. Tsichlis. 1997. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA 94:3627.
50. Kauffmann-Zeh, A., P. Rodriguez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through P13K and PKB. Nature 385:544.
51. Brennan, P., J. W. Babbage, B. M. Burgering, B. Groner, K. Reif, and D. A. Cantrell. 1997. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7:679.
52. Perkins, G. R., J. Marvel, and M. K. Collins. 1993. Interleukin 2 activates extracellular signal-regulated protein kinase 2. J. Exp. Med 178:1429.
53. Crawley, J. B., L. Rawlinson, F. V. Lali, T. H. Page, J. Saklatvala, and B. M. Foxwell. 1997. T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J. Biol. Chem. 272:15023.
54. Kaplan, M. H., Y. L. Sun, T. Hoey, and M. J. Grusby. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174.
55. Cho, S. S., C. M. Bacon, C. Sudarshan, R. C. Rees, D. Finbloom, R. Pine, and J. J. O'Shea. 1996. Activation of STAT4 by IL-12 and IFN-α: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 257:4781.
56. Ellery, J. M., and P. J. Nicholls. 2002. Possible mechanism for the a subunit of the interleukin-2 receptor (CD25) to influence interleukin-2 receptor signal transduction. Immunol. Cell Biol. 80:351.
57. Reif, K., B. M. Burgering, and D. A. Cantrell. 1997. Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J. Biol. Chem. 272:14426.
58. Fairhurst, R. M., M. Daeipour, M. C. Amaral, and A. E. Nel. 1993. Activation of mitogen-activated protein kinase/ERK-2 in phytohaemagglutin in blasts by recombinant interleukin-2: contrasting features with CD3 activation. Immunology 79:112.
59. Xu, W., M. Yan, L. Lu, L. Sun, J. Theze, Z. Zheng, and X. Liu. 2001. The p38 MAPK pathway is involved in the IL-2 induction of TNF-β gene via the EBS element. Biochem. Biophys. Res. Commun. 289:979.
60. Ravichandran, K. S., and S. J. Burakoff. 1994. Evidence for differential intracellular signaling via CD4 and CD8 molecules. J. Exp. Med. 179:727.
61. Fernandez-Segura, E., J. M. Garcia, J. A. Lopez-Escamez, and A. Campos. 1994. Surface expression and distribution of Fc receptor III (CD16 molecule) on human natural killer cells and polymorphonuclear neutrophils. Microsc. Res. Tech. 28:277.
62. Borrego, F., J. Pena, and R. Solana. 1993. Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases. Eur. J. Immunol. 23:1039.
63. Rajagopalan, S., J. Fu, and E. O. Long. 2001. Cutting edge: induction of IFN-γ production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J. Immunol. 167:1877.
64. Sulica, A., D. Metes, M. Gherman, T. L. Whiteside, and R. B. Herberman. 1996. Divergent effects of FcγRIIIA ligands on the functional activities of human natural killer cells in vitro. Eur. J. Immunol. 26:1199.
65. Zhou, J., J. Zhang, M. G. Lichtenheld, and G. G. Meadows. 2002. A role for NF-κB activation in perforin expression of NK cells upon IL-2 receptor signaling. J. Immunol. 169:1319.
66. Yamamoto, K., F. Shibata, N. Miyasaka, and O. Miura. 2002. The human perforin gene is a direct target of STAT4 activated by IL-12 in NK cells. Biochem. Biophys. Res. Commun. 297:1245.
67. Lawless, V. A., S. Zhang, O. N. Ozes, H. A. Bruns, I. Oldham, T. Hoey, M. J. Grusby, and M. H. Kaplan. 2000. Stat4 regulates multiple components of IFN-γ-inducing signaling pathways. J. Immunol. 165:6803.
68. Wesch, D., S. Marx, and D. Kabelitz. 1997. Comparative analysis of αβ and γδ T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate. Eur. J. Immunol. 27:952.
69. + T cells during mycobacterial infections. Science 295:2255.
70. Moris, A., S. Rothenfusser, E. Meuer, R. Hangretinger, and P. Fisch. 1999. Role of γδ T cells in tumor immunity and their control by NK receptors. Microbes Infect. 1:227.